Efficacy of sumamigren at early and late stages of migraine attack
Three migraine attacks have been studied in 30 patients aged 39.4+/-10.5 years. A significant decrease of headache and concomitant symptoms was found 1, 2 and 6 h after receiving of sumamigren (sumatriptan). The drug was effective in 2 out of 3 attacks in most of the patients (53.3%); in 3 attacks--in 26.7%; in 1 attack--in 6.7%. In 13.3% of the patients the drug did not exert a therapeutic effect. When administering at the early stage of the attack, the drug reduced the headache after 1 and 2 h more significantly comparing to patients receiving it at the later stage. In case of early prescription of sumamigren, the relapse of headache was observed in 7,8% and in later one--in 20.5% of patients. During the first 24 h of attack, patients switched to the drug at the early stage reported higher quality of life (mean score 45.1+/-14.6) than those with later prescription (71.4+/-18.3). It has been concluded that sumamigren is an effective medication for stopping the migraine attack, in particular at its the beginning.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2007 |
---|---|
Erschienen: |
2007 |
Enthalten in: |
Zur Gesamtaufnahme - volume:107 |
---|---|
Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 107(2007), 8 vom: 01., Seite 29-33 |
Sprache: |
Russisch |
---|
Beteiligte Personen: |
Tabeeva, G R [VerfasserIn] |
---|
Themen: |
8R78F6L9VO |
---|
Anmerkungen: |
Date Completed 02.09.2008 Date Revised 18.10.2016 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM178613835 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM178613835 | ||
003 | DE-627 | ||
005 | 20231223152407.0 | ||
007 | tu | ||
008 | 231223s2007 xx ||||| 00| ||rus c | ||
028 | 5 | 2 | |a pubmed24n0595.xml |
035 | |a (DE-627)NLM178613835 | ||
035 | |a (NLM)18379469 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
100 | 1 | |a Tabeeva, G R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Efficacy of sumamigren at early and late stages of migraine attack |
264 | 1 | |c 2007 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 02.09.2008 | ||
500 | |a Date Revised 18.10.2016 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Three migraine attacks have been studied in 30 patients aged 39.4+/-10.5 years. A significant decrease of headache and concomitant symptoms was found 1, 2 and 6 h after receiving of sumamigren (sumatriptan). The drug was effective in 2 out of 3 attacks in most of the patients (53.3%); in 3 attacks--in 26.7%; in 1 attack--in 6.7%. In 13.3% of the patients the drug did not exert a therapeutic effect. When administering at the early stage of the attack, the drug reduced the headache after 1 and 2 h more significantly comparing to patients receiving it at the later stage. In case of early prescription of sumamigren, the relapse of headache was observed in 7,8% and in later one--in 20.5% of patients. During the first 24 h of attack, patients switched to the drug at the early stage reported higher quality of life (mean score 45.1+/-14.6) than those with later prescription (71.4+/-18.3). It has been concluded that sumamigren is an effective medication for stopping the migraine attack, in particular at its the beginning | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 7 | |a Serotonin Receptor Agonists |2 NLM | |
650 | 7 | |a Sumatriptan |2 NLM | |
650 | 7 | |a 8R78F6L9VO |2 NLM | |
700 | 1 | |a Azimova, Iu E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 107(2007), 8 vom: 01., Seite 29-33 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
773 | 1 | 8 | |g volume:107 |g year:2007 |g number:8 |g day:01 |g pages:29-33 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 107 |j 2007 |e 8 |b 01 |h 29-33 |